Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00755326 · ClinicalTrials.gov registry record · Phase 2
Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT00755326 is a Phase 2 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 92 participants.
The verdict
NCT00755326, a Phase 2 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the traditional Chinese herbal compound (Huo-Luo-Xiao-Ling Dan, or HLXL) is effective in treating OA of the knee in addition to participants current OA of the knee treatment(s) and also to determine the best dosage of HLXL that is safe and well tolerated.
Interventions
- DRUG HLXL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00755326
The ClinicalTrials.gov registry entry for NCT00755326 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HLXL is the first listed.
NCT00755326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00755326 about?
NCT00755326 is a clinical study titled "Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee". The purpose of this study is to determine if the traditional Chinese herbal compound (Huo-Luo-Xiao-Ling Dan, or HLXL) is effective in treating OA of the knee in addition to participants current OA of the knee treatment(s) and also to determine the best dosage of HLXL that is safe and well tolerated.
What is the current status of trial NCT00755326?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2007-04. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00755326?
The interventions under investigation include: HLXL (DRUG).
Who is sponsoring clinical trial NCT00755326?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.